Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for GoodRx Holdings, Inc. (GDRX : NSDQ)
 
 • Company Description   
GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California.

Number of Employees: 697

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.96 Daily Weekly Monthly
20 Day Moving Average: 948,900 shares
Shares Outstanding: 342.57 (millions)
Market Capitalization: $1,014.02 (millions)
Beta: 1.60
52 Week High: $5.81
52 Week Low: $1.77
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5.71% 4.89%
12 Week 16.08% 13.23%
Year To Date 9.23% 0.88%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2701 OLYMPIC BOULEVARD
-
SANTA MONICA,CA 90404
USA
ph: 855-268-2822
fax: -
ir@goodrx.com http://www.goodrx.com
 
 • General Corporate Information   
Officers
Wendy Barnes - Chief Executive Officer and President
Trevor Bezdek - Chairman
Christopher McGinnis - Chief Financial Officer
Romin Nabiey - Chief Accounting Officer
Christopher Adams - Director

Peer Information
GoodRx Holdings, Inc. (CHCR)
GoodRx Holdings, Inc. (ESRX)
GoodRx Holdings, Inc. (MYDP)
GoodRx Holdings, Inc. (COR)
GoodRx Holdings, Inc. (GBCS)
GoodRx Holdings, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 38246G108
SIC: 7374
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/05/26
Share - Related Items
Shares Outstanding: 342.57
Most Recent Split Date: (:1)
Beta: 1.60
Market Capitalization: $1,014.02 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.05 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.17 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 12.96% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 17.76
Trailing 12 Months: 18.50
PEG Ratio: 1.37
Price Ratios
Price/Book: 1.63
Price/Cash Flow: 7.40
Price / Sales: 1.29
EPS Growth
vs. Year Ago Period: -40.00%
vs. Previous Quarter: -25.00%
Sales Growth
vs. Year Ago Period: -4.42%
vs. Previous Quarter: -0.40%
ROE
06/30/26 - -
03/31/26 - 7.90
12/31/25 - 9.31
ROA
06/30/26 - -
03/31/26 - 3.23
12/31/25 - 4.38
Current Ratio
06/30/26 - -
03/31/26 - 1.47
12/31/25 - 2.61
Quick Ratio
06/30/26 - -
03/31/26 - 1.47
12/31/25 - 2.61
Operating Margin
06/30/26 - -
03/31/26 - 6.22
12/31/25 - 7.35
Net Margin
06/30/26 - -
03/31/26 - 2.61
12/31/25 - 3.82
Pre-Tax Margin
06/30/26 - -
03/31/26 - 5.78
12/31/25 - 7.10
Book Value
06/30/26 - -
03/31/26 - 1.82
12/31/25 - 1.81
Inventory Turnover
06/30/26 - -
03/31/26 - -
12/31/25 - -
Debt-to-Equity
06/30/26 - -
03/31/26 - 0.78
12/31/25 - 0.78
Debt-to-Capital
06/30/26 - -
03/31/26 - 43.68
12/31/25 - 43.95
 

Powered by Zacks Investment Research ©